Inventor
REGUEIRO-REN ALICIA
US46 patents
⚠️ This page may combine multiple inventors who share the name “REGUEIRO-REN ALICIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
27 patentsUS7354924B2Apr 8, 2008
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
BRISTOL MYERS SQUIBB CO106 citations99
US6291684B1Sep 18, 2001
Process for the preparation of aziridinyl epothilones from oxiranyl epothilones
BRISTOL MYERS SQUIBB CO76 citations96
US7807676B2Oct 5, 2010
Diketo-Piperazine and Piperidine derivatives as antiviral agents
BRISTOL MYERS SQUIBB CO17 citations92
US7807671B2Oct 5, 2010
Diketo-piperazine and piperidine derivatives as antiviral agents
BRISTOL MYERS SQUIBB CO29 citations92
US7662823B2Feb 16, 2010
Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives
BRISTOL MYERS SQUIBB CO17 citations92
US7501420B2Mar 10, 2009
Composition and antiviral of substituted azaindoleoxoacetic piperazine derivatives
BRISTOL MYERS SQUIBB CO21 citations92
US7473688B2Jan 6, 2009
Indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO26 citations92
US6900206B2May 31, 2005
Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
BRISTOL MYERS SQUIBB CO28 citations92
US6719540B2Apr 13, 2004
C3-cyano epothilone derivatives
BRISTOL MYERS SQUIBB CO24 citations92
US8906889B2Dec 9, 2014
C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
BRISTOL MYERS SQUIBB CO12 citations84
US7960406B2Jun 14, 2011
Diketo substituted pyrrolo[2,3-c] pyridines
BRISTOL MYERS SQUIBB CO5 citations74
US11267811B2Mar 8, 2022
Small molecule inhibitors of galectin-3
BRISTOL MYERS SQUIBB CO4 citations72
US11072626B2Jul 27, 2021
Small molecule inhibitors of Galectin-3
BRISTOL MYERS SQUIBB CO3 citations71
US8754069B2Jun 17, 2014
Betulinic acid derivatives with antiviral activity
BRISTOL MYERS SQUIBB CO2 citations63
US7211593B2May 1, 2007
C12-cyano epothilone derivatives
BRISTOL MYERS SQUIBB CO3 citations63
US7183284B2Feb 27, 2007
Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents
BRISTOL MYERS SQUIBB CO6 citations63
US12275719B2Apr 15, 2025
Small molecule inhibitors of galectin-3
BRISTOL MYERS SQUIBB CO0 citations62
US7022667B2Apr 4, 2006
O-derivatized nocathiacin derivatives
BRISTOL MYERS SQUIBB CO5 citations62
US12590091B2Mar 31, 2026
1H-pyrrolo[3,2-C]pyridine and 1H-pyrrolo[2,3-C]pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis
BRISTOL MYERS SQUIBB CO0 citations52
US12291522B2May 6, 2025
Galectin-3 inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US8889854B2Nov 18, 2014
C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
BRISTOL MYERS SQUIBB CO1 citations52
US12486267B2Dec 2, 2025
Imidazo[1,2-A]pyridine and [1,2,4]triazolo[1,5-A]pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis
BRISTOL MYERS SQUIBB CO0 citations51
US12275718B2Apr 15, 2025
Small molecule inhibitors of galectin-3
BRISTOL MYERS SQUIBB CO0 citations51
US12269819B2Apr 8, 2025
Small molecule inhibitors of Galectin-3
BRISTOL MYERS SQUIBB CO0 citations51
US12492188B2Dec 9, 2025
1H-benzo[D]imidazole derivatives as TLR9 inhibitors for the treatment of fibrosis
BRISTOL MYERS SQUIBB CO0 citations50
US11970511B2Apr 30, 2024
Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
BRISTOL MYERS SQUIBB CO0 citations50
US9249180B2Feb 2, 2016
C-3 alkyl and alkenyl modified betulinic acid derivatives
BRISTOL MYERS SQUIBB CO0 citations42
VIIV HEALTHCARE UK NO 5 LTD
7 patentsUS11084845B2Aug 10, 2021
C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
VIIV HEALTHCARE UK NO 5 LTD1 citations62
US10421774B2Sep 24, 2019
C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
VIIV HEALTHCARE UK NO 5 LTD1 citations62
US9969767B2May 15, 2018
Oxolupene derivatives
VIIV HEALTHCARE UK NO 5 LTD1 citations52
US9914747B2Mar 13, 2018
Extended betulinic acid analogs
VIIV HEALTHCARE UK NO 5 LTD0 citations52
US10493070B2Dec 3, 2019
Azadecalin derivatives as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD0 citations42
US10047118B2Aug 14, 2018
C17-aryl substituted betulinic acid analogs
VIIV HEALTHCARE UK NO 5 LTD0 citations42
US9920090B2Mar 20, 2018
Betulinic acid derivatives with HIV maturation inhibitory activity
VIIV HEALTHCARE UK NO 5 LTD0 citations40
REGUEIRO-REN ALICIA
5 patentsUS8846647B2Sep 30, 2014
C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activity
REGUEIRO-REN ALICIA19 citations83
US8802661B2Aug 12, 2014
C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitors
REGUEIRO-REN ALICIA14 citations83
US8754068B2Jun 17, 2014
Modified C-3 betulinic acid derivatives as HIV maturation inhibitors
REGUEIRO-REN ALICIA15 citations83
US8748415B2Jun 10, 2014
C-28 amines of C-3 modified betulinic acid derivatives as HIV maturation inhibitors
REGUEIRO-REN ALICIA16 citations83
US8242124B2Aug 14, 2012
Diketopiperidine derivatives as HIV attachment inhibitors
REGUEIRO-REN ALICIA3 citations62
VIIV HEALTHCARE UK NO 4 LTD
3 patentsUS11464790B2Oct 11, 2022
Triterpenoids with HIV maturation inhibitory activity
VIIV HEALTHCARE UK NO 4 LTD0 citations62
US10780102B2Sep 22, 2020
Triterpenoids with HIV maturation inhibitory activity
VIIV HEALTHCARE UK NO 4 LTD0 citations51
US10245275B2Apr 2, 2019
Triterpenoids with HIV maturation inhibitory activity
VIIV HEALTHCARE UK NO 4 LTD0 citations51